Physician profile
John A Andre
NPI 1740608942
$2,622.40
in general payments reported to CMS, 2019-2025
9 companies · $59.66 in 2025
The $59.66 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $804 · 2023: $1,146 · 2024: $613 · 2025: $59.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,818.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $757.99 | 2022-2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Abbvie INC. | $611.88 | 2023-2024 | Natrelle Saline-Filled Breast Implants, Alloderm |
| Allergan, INC. | $531.97 | 2022 | |
| Rti Surgical, INC | $219.15 | 2023-2024 | |
| Baxter Healthcare | $186.28 | 2023-2024 | Tisseel, Coseal |
| Integra Lifesciences Corporation | $134.14 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Endo Pharmaceuticals INC. | $124.99 | 2023 | Xiaflex |
| Pacira Pharmaceuticals Incorporated | $29.06 | 2024 | Exparel |
| Biocircuit Technologies INC | $26.94 | 2025 | Nerve Tape |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Andre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.